JCI - Citations to The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.

Citations to this article

The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.

I V Fuki, … , E A Fisher, K J Williams

I V Fuki, … , E A Fisher, K J Williams

Published September 15, 1997
Citation Information: J Clin Invest. 1997;100(6):1611-1622. https://doi.org/10.1172/JCI119685.

View: Text | PDF

Research Article

Total citations by year

Year:	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1996	1991	Total
Citations:	1	2	1	2	11	4	3	3	3	4	11	8	4	14	8	14	8	9	6	11	9	11	5	12	12	12	12	1	1	202

Citation information

Citations to this article (202)

Title and authors	Publication	Year
Genetic modifiers of body mass index in individuals with cystic fibrosis. Ling H, Raraigh KS, Pugh EW, Aksit MA, Zhang P, Pace RG, Faino AV, Bamshad MJ, Gibson RL, O'Neal W, Knowles MR, Blackman SM, Cutting GR	American journal of human genetics	2024
The association between a genetic variant in the SULF2 gene, metabolic parameters and vascular disease in patients at high cardiovascular risk Heidemann BE, Visseren FL, van Setten J, Marais AD, Koopal C	Cardiovascular endocrinology & metabolism	2023
Global impact of proteoglycan science on human diseases Xie C, Schaefer L, Iozzo RV	iScience	2023
Receptor control by membrane-tethered ubiquitin ligases in development and tissue homeostasis. Lebensohn AM, Bazan JF, Rohatgi R	Current topics in developmental biology	2022
Hypercholesterolemia in Progressive Renal Failure Is Associated with Changes in Hepatic Heparan Sulfate - PCSK9 Interaction P Shrestha, S Adepu, RR Vivès, RE Masri, A Klooster, F Kaptein, W Dam, SJ Bakker, H van Goor, B van de Sluis, J van den Born	Journal of the American Society of Nephrology : JASN	2021
Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine H Moorthy, T Govindaraju		2021
Heparanase: From Basic Research to Clinical Applications I Vlodavsky, RD Sanderson, N Ilan		2020
Heparanase: From Basic Research to Clinical Applications I Vlodavsky, RD Sanderson, N Ilan		2020
Heparanase: From Basic Research to Clinical Applications I Vlodavsky, RD Sanderson, N Ilan		2020
Heparanase: From Basic Research to Clinical Applications I Vlodavsky, RD Sanderson, N Ilan		2020
Heparanase: From Basic Research to Clinical Applications I Vlodavsky, RD Sanderson, N Ilan		2020
Heparanase: From Basic Research to Clinical Applications I Vlodavsky, RD Sanderson, N Ilan		2020
Heparanase: From Basic Research to Clinical Applications I Vlodavsky, RD Sanderson, N Ilan		2020
Heparanase: From Basic Research to Clinical Applications I Vlodavsky, RD Sanderson, N Ilan		2020
Heparanase: From Basic Research to Clinical Applications I Vlodavsky, RD Sanderson, N Ilan		2020
Heparanase: From Basic Research to Clinical Applications I Vlodavsky, RD Sanderson, N Ilan		2020
Heparanase: From Basic Research to Clinical Applications I Vlodavsky, RD Sanderson, N Ilan		2020
Factors Enhancing Serum Syndecan-1 Concentrations: A Large-Scale Comprehensive Medical Examination K Oda, H Okada, A Suzuki, H Tomita, R Kobayashi, K Sumi, K Suzuki, C Takada, T Ishihara, K Suzuki, S Kano, K Kondo, Y Iwashita, H Yano, R Zaikokuji, S Sampei, T Fukuta, Y Kitagawa, H Okamoto, T Watanabe, T Kawaguchi, T Kojima, F Deguchi, N Miyazaki, N Yamada, T Doi, T Yoshida, H Ushikoshi, S Yoshida, G Takemura, S Ogura	Journal of Clinical Medicine	2019
Triglyceride-rich lipoprotein binding and uptake by heparan sulfate proteoglycan receptors in a CRISPR/Cas9 library of Hep3B mutants F Anower-E-Khuda, G Singh, Y Deng, PL Gordts, JD Esko	Glycobiology	2019
Novel aspects of PCSK9 and lipoprotein receptors in renal disease-related dyslipidemia P Shrestha, B van de Sluis, RP Dullaart, J van den Born	Cellular Signalling	2019
Next generation sequencing and RNA-seq characterization of adipose tissue in the Nile crocodile (Crocodylus niloticus) in South Africa: Possible mechanism(s) of pathogenesis and pathophysiology of pansteatitis OI Azeez, JG Myburgh, AM Bosman, J Featherston, KP Sibeko-Matjilla, MC Oosthuizen, JP Chamunorwa, JA Deiuliis	PloS one	2019
The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis PL Gordts, JD Esko	Matrix biology : journal of the International Society for Matrix Biology	2018
Dually modified transmembrane proteoglycans in development and disease LM Jenkins, B Horst, CL Lancaster, K Mythreye	Cytokine & Growth Factor Reviews	2018
Endovascular Interventions JM Wiley, C Sanina, P Faries, ID Conde, GD Dangas, P Krishnan		2018
Suppression of Hepatic FLOT1 (Flotillin-1) by Type 2 Diabetes Mellitus Impairs the Disposal of Remnant Lipoproteins via Syndecan-1Highlights K Chen, Q Wu, K Hu, C Yang, X Wu, P Cheung, KJ Williams	Arteriosclerosis, thrombosis, and vascular biology	2017
Heparan sulfate proteoglycans present PCSK9 to the LDL receptor C Gustafsen, D Olsen, J Vilstrup, S Lund, A Reinhardt, N Wellner, T Larsen, CB Andersen, K Weyer, J Li, PH Seeberger, S Thirup, P Madsen, S Glerup	Nature Communications	2017
Angiopoietin-like 4 Is a Wnt Signaling Antagonist that Promotes LRP6 Turnover N Kirsch, LS Chang, S Koch, A Glinka, C Dolde, G Colozza, MD Benitez, EM de Robertis, C Niehrs	Developmental Cell	2017
Imbalanced insulin action in chronic over nutrition: Clinical harm, molecular mechanisms, and a way forward KJ Williams, X Wu	Atherosclerosis	2016
Glucuronic Acid Epimerase (GLCE) Variant rs3865014 (A>G) Is Associated with BMI, Blood Hemoglobin, Hypertension, and Cerebrovascular Events, the TAMRISK Study: Glucuronic acid Epimerase Variant and Cardiometabolic Risk T Kunnas, T Solakivi, K Määttä, ST Nikkari	Annals of Human Genetics	2016
Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy C Koopal, AD Marais, J Westerink, FL Visseren	Journal of Clinical Lipidology	2016
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans RV Iozzo, L Schaefer	Matrix Biology	2015
Decoding the Matrix: Instructive Roles of Proteoglycan Receptors T Neill, L Schaefer, RV Iozzo	Biochemistry	2015
Chylomicron remnant model emulsions induce intracellular cholesterol accumulation and cell death due to lysosomal destabilization K Wakita, S Morita, N Okamoto, E Takata, T Handa, M Nakano	Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids	2015
Atherosclerosis: Risks, Mechanisms, and Therapies HJ Pownall, C Rosales, BK Gillard, AM Gotto	Atherosclerosis: Risks, Mechanisms, and Therapies	2015
Syndecan-1 and Its Expanding List of Contacts MA Stepp, S Pal-Ghosh, G Tadvalkar, A Pajoohesh-Ganji	Advances in Skin & Wound Care	2014
Processing of heparanase is mediated by syndecan-1 cytoplasmic domain and involves syntenin and α-actinin A Shteingauz, N Ilan, I Vlodavsky	Cellular and Molecular Life Sciences	2014
SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus: SULF2 and Triglycerides in Obesity HC Hassing, RP Surendran, B Derudas, A Verrijken, SM Francque, HL Mooij, SJ Moens, LM Hart, G Nijpels, JM Dekker, KJ Williams, ES Stroes, LF van Gaal, B Staels, M Nieuwdorp, GM Dallinga-Thie	Obesity	2014
Recent advances in physiological lipoprotein metabolism I Ramasamy	Clinical Chemistry and Laboratory Medicine	2014
Regression of Atherosclerosis: Insights from Animal and Clinical Studies JE Feig	Annals of Global Health	2014
Postprandial hypertriglyceridemia as a coronary risk factor J Borén, N Matikainen, M Adiels, MR Taskinen	Clinica Chimica Acta	2014
Endothelial Cell Heparanase Taken Up by Cardiomyocytes Regulates Lipoprotein Lipase Transfer to the Coronary Lumen After Diabetes Y Wang, AP Chiu, K Neumaier, F Wang, D Zhang, B Hussein, N Lal, A Wan, G Liu, I Vlodavsky, B Rodrigues	Diabetes	2014
Reply to "Heparan Sulfate in Baculovirus Binding and Entry of Mammalian Cells" KE Makkonen, P Turkki, JP Laakkonen, S Yla-Herttuala, V Marjomaki, KJ Airenne	Journal of virology	2014
Endothelial glycocalyx of blood circulation system. II. Biological functions, state under normal and pathological conditions, and bioengineering applications AV Maksimenko, AD Turashev	Russian Journal of Bioorganic Chemistry	2014
Acidification of the intimal fluid: the perfect storm for atherogenesis K Öörni, K Rajamäki, SD Nguyen, K Lähdesmäki, R Plihtari, M Lee-Rueckert, PT Kovanen	Journal of lipid research	2014
Hepatic Syndecan-1 Changes Associate With Dyslipidemia After Renal Transplantation: Liver Syndecan-1 in Renal Transplantation S Adepu, K Katta, UJ Tietge, AJ Kwakernaak, W Dam, H Goor, RP Dullaart, GJ Navis, SJ Bakker, J Born	American Journal of Transplantation	2014
Apolipoproteins E and AV Mediate Lipoprotein Clearance by Hepatic Proteoglycans Jon C. Gonzales, Philip L.S.M. Gordts, Erin M. Foley, Jeffrey D. Esko	Journal of Clinical Investigation	2013
Dendrimer Nanoscaffolds for Potential Theranostics of Prostate Cancer with a Focus on Radiochemistry ST Lo, A Kumar, JT Hsieh, X Sun	Molecular Pharmaceutics	2013
Genetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjects N Matikainen, MA Burza, S Romeo, A Hakkarainen, M Adiels, L Folkersen, P Eriksson, N Lundbom, E Ehrenborg, M Orho-Melander, MR Taskinen, J Borén	PloS one	2013
Molecular mediators for raft-dependent endocytosis of syndecan-1, a highly conserved, multifunctional receptor K Chen, KJ Williams	The Journal of biological chemistry	2013
6-o- and N-sulfated syndecan-1 promotes baculovirus binding and entry into Mammalian cells KE Makkonen, P Turkki, JP Laakkonen, S Ylä-Herttuala, V Marjomäki, KJ Airenne	Journal of virology	2013
Cell susceptibility to baculovirus transduction and echovirus infection is modified by protein kinase C phosphorylation and vimentin organization P Turkki, KE Makkonen, M Huttunen, JP Laakkonen, S Ylä-Herttuala, KJ Airenne, V Marjomäki	Journal of virology	2013
Genetic Variation in SULF2 Is Associated with Postprandial Clearance of Triglyceride-Rich Remnant Particles and Triglyceride Levels in Healthy Subjects N Matikainen, MA Burza, S Romeo, A Hakkarainen, M Adiels, L Folkersen, P Eriksson, N Lundbom, E Ehrenborg, M Orho-Melander, MR Taskinen, J Borén, DC Crawford	PloS one	2013
Lipoproteins in Diabetes Mellitus AJ Jenkins, PP Toth, TJ Lyons		2013
A new, powerful player in lipoprotein metabolism: brown adipose tissue A Bartelt, M Merkel, J Heeren	Journal of Molecular Medicine	2012
Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemia HC Hassing, H Mooij, S Guo, BP Monia, K Chen, W Kulik, GM Dallinga-Thie, M Nieuwdorp, ES Stroes, KJ Williams	Hepatology	2012
Inhibition of PDGF-B Induction and Cell Growth by Syndecan-1 Involves the Ubiquitin and SUMO-1 Ligase, Topors KR Braun, AM Dewispelaere, SL Bressler, N Fukai, RD Kenagy, L Chen, AW Clowes, MG Kinsella	PloS one	2012
Syndecan-2 can promote clearance of T-cell receptor/CD3 from the cell surface X Rovira-Clavé, M Angulo-Ibáñez, O Noguer, E Espel, M Reina	Immunology	2012
Role of heparanase on hepatic uptake of intestinal derived lipoprotein and fatty streak formation in mice D Planer, S Metzger, E Zcharia, ID Wexler, I Vlodavsky, T Chajek-Shaul	PloS one	2011
Shedding of syndecan-1 from human hepatocytes alters VLDL clearance Y Deng, EM Foley, JC Gonzales, PL Gordts, Y Li, JD Esko	Hepatology	2011
Heparan sulfate proteoglycans S Sarrazin, WC Lamanna, JD Esko	Cold Spring Harbor perspectives in biology	2011
Molecular functions of syndecan-1 in disease YH Teng, RS Aquino, PW Park	Matrix Biology	2011
Lipoprotein Lipase Inhibits Hepatitis C Virus (HCV) Infection by Blocking Virus Cell Entry P Maillard, M Walic, P Meuleman, F Roohvand, T Huby, WL Goff, G Leroux-Roels, EI Pécheur, A Budkowska	PloS one	2011
The heparanase system and tumor metastasis: is heparanase the seed and soil? G Arvatz, I Shafat, F Levy-Adam, N Ilan, I Vlodavsky	Cancer and Metastasis Reviews	2011
Eicosapentaenoic Acid and Docosahexaenoic Acid Regulate Modified LDL Uptake and Macropinocytosis in Human Macrophages JE McLaren, DR Michael, IA Guschina, JL Harwood, DP Ramji	Lipids	2011
Rspo3 Binds Syndecan 4 and Induces Wnt/PCP Signaling via Clathrin-Mediated Endocytosis to Promote Morphogenesis B Ohkawara, A Glinka, C Niehrs	Developmental Cell	2011
Recombinant expression, purification, and characterization of transmembrane domain of syndecan-4 TJ Park, MH Lee, JS Kim, Y Kim	Process Biochemistry	2011
Pathophysiology of hypertriglyceridemia HC Hassing, RP Surendran, HL Mooij, ES Stroes, M Nieuwdorp, GM Dallinga-Thie	Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids	2011
Scarless Wound Healing A Nauta, B Larson, MT Longaker, HP Lorenz	Principles of Regenerative Medicine	2011
Challenges in Delivery of Therapeutic Genomics and Proteomics M Kumar, A Misra	Challenges in Delivery of Therapeutic Genomics and Proteomics	2011
Glycans in Diseases and Therapeutics MS Pavão		2011
Heparan Sulfate Proteoglycans in Infection Bartlett AH, Park PW		2011
Type 2 Diabetes in Mice Induces Hepatic Overexpression of Sulfatase 2, a Novel Factor That Suppresses Uptake of Remnant Lipoproteins K Chen, ML Liu, L Schaffer, M Li, G Boden, X Wu, KJ Williams	Hepatology	2010
Tumorigenic and adhesive properties of heparanase F Levy-Adam, N Ilan, I Vlodavsky	Seminars in Cancer Biology	2010
Heparanase 2 Interacts with Heparan Sulfate with High Affinity and Inhibits Heparanase Activity F Levy-Adam, S Feld, V Cohen-Kaplan, A Shteingauz, M Gross, G Arvatz, I Naroditsky, N Ilan, I Doweck, I Vlodavsky	The Journal of biological chemistry	2010
Recent insights into factors affecting remnant lipoprotein uptake KJ Williams, K Chen	Current Opinion in Lipidology	2010
Negative correlation between serum syndecan-1 and apolipoprotein A1 in patients with type 2 diabetes mellitus JB Wang, YJ Zhang, Y Zhang, J Guan, LY Chen, CH Fu, HJ Du, Y Sheng, L Zhou, YF Si, Y Zhang	Acta Diabetologica	2010
Organelle-Specific Pharmaceutical Nanotechnology PG Coupland, JW Aylott	Organelle-Specific Pharmaceutical Nanotechnology	2010
Immunoliposomal systems targeting primary effusion lymphoma:in vitrostudy B Ruozi, G Riva, D Belletti, G Tosi, P Barozzi, M Luppi, F Forni, MA Vandelli	Nanomedicine	2010
Recent insights into factors affecting remnant lipoprotein uptake: KJ Williams, K Chen	Current Opinion in Lipidology	2010
Loss-of-function variants in endothelial lipase are a cause of elevated high density lipoprotein cholesterol in humans Andrew C. Edmondson, Robert J. Brown, Sekar Kathiresan, L. Adrienne Cupples, Serkalem Demissie, Alisa Knodle Manning, Majken Jensen, Eric B. Rimm, Jian Wang, Amrith Rodrigues, Megan L. Wolfe, Stephanie DerOhannessian, Mingyao Li, Muredach Reilly, Jens Aberle, David Evans, Robert A. Hegele, Daniel J. Rader	Journal of Clinical Investigation	2009
Syndecan-1, the Primary Heparan Sulfate Proteoglycan Mediating Hepatic Triglyceride-Rich Lipoprotein Clearance In Vivo Kristin I. Stanford, Joseph R. Bishop, Erin M. Foley, Jon C. Gonzalez, Ingrid R. Niesman, Joseph L. Witztum, Jeffrey D. Esko	Journal of Clinical Investigation	2009
Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL BB Boyanovsky, P Shridas, M Simons, DR van der Westhuyzen, NR Webb	Journal of lipid research	2009
Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance KI Stanford, L Wang, J Castagnola, D Song, JR Bishop, JR Brown, R Lawrence, X Bai, H Habuchi, M Tanaka, WV Cardoso, K Kimata, JD Esko	The Journal of biological chemistry	2009
A naturally occurring variant of endothelial lipase associated with elevated HDL exhibits impaired synthesis RJ Brown, AC Edmondson, N Griffon, TB Hill, IV Fuki, KO Badellino, M Li, ML Wolfe, MP Reilly, DJ Rader	Journal of lipid research	2009
Aggregated LDL in Contact With Macrophages Induces Local Increases in Free Cholesterol Levels That Regulate Local Actin Polymerization I Grosheva, AS Haka, C Qin, LM Pierini, FR Maxfield	Arteriosclerosis, thrombosis, and vascular biology	2009
The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight GM Dallinga-Thie, R Franssen, HL Mooij, ME Visser, HC Hassing, F Peelman, JJ Kastelein, M Péterfy, M Nieuwdorp	Atherosclerosis	2009
ScFv antibody-induced translocation of cell-surface heparan sulfate proteoglycan to endocytic vesicles: evidence for heparan sulfate epitope specificity and role of both syndecan and glypican A Wittrup, SH Zhang, GB Dam, TH van Kuppevelt, P Bengtson, M Johansson, J Welch, M Mörgelin, M Belting	The Journal of biological chemistry	2009
The signaling mechanisms of syndecan heparan sulfate proteoglycans K Lambaerts, SA Wilcox-Adelman, P Zimmermann	Current Opinion in Cell Biology	2009
Apolipoprotein E peptide-modified colloidal carriers: The design determines the mechanism of uptake in vascular endothelial cells E Leupold, H Nikolenko, M Dathe	Biochimica et Biophysica Acta (BBA) - Biomembranes	2009
Syndecan-1 mediates the coupling of positively charged submicrometer amorphous silica particles with actin filaments across the alveolar epithelial cell membrane G Orr, DJ Panther, KJ Cassens, JL Phillips, BJ Tarasevich, JG Pounds	Toxicology and Applied Pharmacology	2009
Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease LN Broekhuizen, HL Mooij, JJ Kastelein, ES Stroes, H Vink, M Nieuwdorp	Current Opinion in Lipidology	2009
Heparan sulfate proteoglycans: structure, protein interactions and cell signaling JL Dreyfuss, CV Regatieri, TR Jarrouge, RP Cavalheiro, LO Sampaio, HB Nader	Anais da Academia Brasileira de Ciências	2009
Heparan Sulfate 2- O -Sulfotransferase Is Required for Triglyceride-rich Lipoprotein Clearance KI Stanford, L Wang, J Castagnola, D Song, JR Bishop, JR Brown, R Lawrence, X Bai, H Habuchi, M Tanaka, WV Cardoso, K Kimata, JD Esko	The Journal of biological chemistry	2009
Molecular processes that handle – and mishandle – dietary lipids Kevin Jon Williams	Journal of Clinical Investigation	2008
Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: a pathway for late-stage quality control M Pan, V Maitin, S Parathath, U Andreo, SX Lin, CS Germain, Z Yao, FR Maxfield, KJ Williams, EA Fisher	Proceedings of the National Academy of Sciences	2008
Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism JR Bishop, KI Stanford, JD Esko	Current Opinion in Lipidology	2008
Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation K Tran-Lundmark, PK Tran, G Paulsson-Berne, V Fridén, R Soininen, K Tryggvason, TN Wight, MG Kinsella, J Borén, U Hedin	Circulation research	2008
Cytotoxicity of lipid-free apolipoprotein B S Morita, Y Deharu, E Takata, M Nakano, T Handa	Biochimica et Biophysica Acta (BBA) - Biomembranes	2008
Non-enzymatic developmental functions of acetylcholinesterase - the question of redundancy G Johnson, C Swart, SW Moore	FEBS Journal	2008
Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A 2 -modified LDL BB Boyanovsky, P Shridas, M Simons, DR van der Westhuyzen, NR Webb	Journal of lipid research	2008
Opposing Roles of Syndecan-1 and Syndecan-2 in Polyethyleneimine-mediated Gene Delivery S Paris, A Burlacu, Y Durocher	The Journal of biological chemistry	2008
Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members Jennifer M. MacArthur Joseph R. Bishop Kristin I. Stanford Lianchun Wang André Bensadoun Joseph L. Witztum Jeffrey D. Esko	Journal of Clinical Investigation	2007
Atherogenic remnant lipoproteins: trap, transfer, and internalization role for proteoglycans Robert W. Mahley, Yadong Huang	Journal of Clinical Investigation	2007
Obesity causes very low density lipoprotein clearance defects in low-density lipoprotein receptor-deficient mice KR Coenen, ML Gruen, AH Hasty	The Journal of Nutritional Biochemistry	2007
Mammalian heparanase: what is the message? V Vreys, G David	Journal of Cellular and Molecular Medicine	2007
Role of adipocyte-derived lipoprotein lipase in adipocyte hypertrophy AM Gonzales, RA Orlando	Nutrition & Metabolism	2007
Syndecans in wound healing, inflammation and vascular biology AN Alexopoulou, HA Multhaupt, JR Couchman	The International Journal of Biochemistry & Cell Biology	2007
Liver heparan sulfate proteoglycans: Old molecules provide new insights on lipoprotein metabolism V Cortés, A Rigotti	Hepatology	2007
Heparan sulphate proteoglycans fine-tune mammalian physiology JR Bishop, M Schuksz, JD Esko	Nature	2007
Glycosylation of endothelial lipase at asparagine-116 reduces activity and the hydrolysis of native lipoproteins in vitro and in vivo RJ Brown, GC Miller, N Griffon, CJ Long, DJ Rader	Journal of lipid research	2007
Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway LC Wilsie, AM Gonzales, RA Orlando	Lipids in Health and Disease	2006
Activation of ERK signaling upon alternative protease nexin-1 internalization mediated by syndecan-1 X Li, J Herz, D Monard	Journal of Cellular Biochemistry	2006
Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophages Y Wegrowski, AL Milard, G Kotlarz, E Toulmonde, FX Maquart, J Bernard	Clinical & Experimental Immunology	2006
Expression of aggrecan(ases) during murine preadipocyte differentiation and adipose tissue development G Voros, JD Sandy, D Collen, HR Lijnen	Biochimica et Biophysica Acta (BBA) - General Subjects	2006
The role of syndecans in disease and wound healing CY Fears, A Woods	Matrix Biology	2006
Inhibition of Glycosaminoglycan Synthesis Using Rhodamine B in a Mouse Model of Mucopolysaccharidosis Type IIIA AL Roberts, BJ Thomas, AS Wilkinson, JM Fletcher, S Byers	Pediatric Research	2006
Induction of a CXCL8 binding site on endothelial syndecan-3 in rheumatoid synovium AM Patterson, L Gardner, J Shaw, G David, E Loreau, L Aguilar, BA Ashton, J Middleton	Arthritis & Rheumatism	2005
Cell surface heparan sulfate proteoglycans contribute to intracellular lipid accumulation in adipocytes LC Wilsie, S Chanchani, D Navaratna, RA Orlando	Lipids in Health and Disease	2005
Trap RACK1 with Ras to mobilize Src signaling at syndecan-2/p120-GAP upon transformation with oncogenic ras JW Huang, CL Chen, NN Chuang	Biochemical and Biophysical Research Communications	2005
Dimerize RACK1 upon transformation with oncogenic ras LY Chu, YH Chen, NN Chuang	Biochemical and Biophysical Research Communications	2005
P120-GAP associated with syndecan-2 to function as an active switch signal for Src upon transformation with oncogenic ras JW Huang, CL Chen, NN Chuang	Biochemical and Biophysical Research Communications	2005
Expression of a secreted form of Dally, a Drosophila glypican, induces overgrowth phenotype by affecting action range of Hedgehog S Takeo, T Akiyama, C Firkus, T Aigaki, H Nakato	Developmental Biology	2005
Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II Kevin Jon Williams, Ming-Lin Liu, Yanqing Zhu, Xiangsheng Xu, William R Davidson, Peter McCue, Kumar Sharma	Diabetes	2005
Plasmin- and Thrombin-accelerated Shedding of Syndecan-4 Ectodomain Generates Cleavage Sites at Lys 114 –Arg 115 and Lys 129 –Val 130 Bonds A Schmidt, F Echtermeyer, A Alozie, K Brands, E Buddecke	The Journal of biological chemistry	2005
Group V Secretory Phospholipase A 2 -modified Low Density Lipoprotein Promotes Foam Cell Formation by a SR-A- and CD36-independent Process That Involves Cellular Proteoglycans BB Boyanovsky, DR van der Westhuyzen, NR Webb	The Journal of biological chemistry	2005
Oxidized linoleic acid regulates expression and shedding of syndecan-4 M Houston, MA Julien, S Parthasarathy, EL Chaikof	American journal of physiology. Cell physiology	2005
Effects of cholesterol in chylomicron remnant models of lipid emulsions on apoE-mediated uptake and cytotoxicity of macrophages A Sakurai, S Morita, K Wakita, Y Deharu, M Nakano, T Handa	Journal of lipid research	2005
Structural basis of endothelial lipase tropism for HDL UC Broedl, W Jin, IV Fuki, JM Glick, DJ Rader	The FASEB Journal	2004
Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism CL Chu, JA Buczek-Thomas, MA Nugent	Biochemical Journal	2004
Role of Syndecan-4 in the cellular invasion of Orientia tsutsugamushi HR Kim, MS Choi, IS Kim	Microbial Pathogenesis	2004
The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity EG Argyris, J Kulkosky, ME Meyer, Y Xu, M Mukhtar, RJ Pomerantz, KJ Williams	Virology	2004
Heparan sulfate proteoglycan mediates the selective attachment and internalization of serotype 3 human adenovirus dodecahedron RR Vivès, H Lortat-Jacob, J Chroboczek, P Fender	Virology	2004
Ceramide in Lipid Particles Enhances Heparan Sulfate Proteoglycan and Low Density Lipoprotein Receptor-related Protein-mediated Uptake by Macrophages S Morita, M Kawabe, A Sakurai, K Okuhira, A Vertut-Doï, M Nakano, T Handa	The Journal of biological chemistry	2004
Lipoprotein lipase-dependent binding and uptake of low density lipoproteins by THP-1 monocytes and macrophages: possible involvement of lipid rafts E Makoveichuk, S Castel, S Vilaró, G Olivecrona	Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids	2004
Role of N-linked glycosylation in the secretion and activity of endothelial lipase GC Miller, CJ Long, ED Bojilova, D Marchadier, KO Badellino, N Blanchard, IV Fuki, JM Glick, DJ Rader	Journal of lipid research	2004
A role for lipoprotein lipase during synaptic remodeling in the adult mouse brain JF Blain, E Paradis, SB Gaudreault, D Champagne, D Richard, J Poirier	Neurobiology of Disease	2004
Syndecans in inflammation M Götte	The FASEB Journal	2003
Syndecans: proteoglycan regulators of cell-surface microdomains? JR Couchman	Nature Reviews Molecular Cell Biology	2003
Heparan sulfate proteoglycan as a plasma membrane carrier M Belting	Trends in Biochemical Sciences	2003
Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin K Okuma, KP Dalton, L Buonocore, E Ramsburg, JK Rose	Journal of virology	2003
Papillomaviruses infect cells via a clathrin-dependent pathway PM Day, DR Lowy, JT Schiller	Virology	2003
Barriers to Nonviral Gene Delivery CM Wiethoff, CR Middaugh	Journal of Pharmaceutical Sciences	2003
Papillomavirus/cell-interactions initiating the infectious entry pathway HC Selinka, M Sapp	Papillomavirus Report	2003
The Low Density Lipoprotein Receptor-related Protein Complexes with Cell Surface Heparan Sulfate Proteoglycans to Regulate Proteoglycan-mediated Lipoprotein Catabolism LC Wilsie, RA Orlando	The Journal of biological chemistry	2003
The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient “apoB-48-only” and “apoB-100-only” mice HL Dichek, K Qian, N Agrawal	Journal of lipid research	2003
Syndecan-1 Expression Is Regulated in an Isoform-specific Manner by the Farnesoid-X Receptor AM Anisfeld, HR Kast-Woelbern, ME Meyer, SA Jones, Y Zhang, KJ Williams, T Willson, PA Edwards	The Journal of biological chemistry	2003
Lectin-like Ox-LDL Receptor Is Expressed in Human INT-407 Intestinal Cells: Involvement in the Transcytosis of Pancreatic Bile Salt–dependent Lipase N Bruneau, S Richard, F Silvy, A Verine, D Lombardo	Molecular biology of the cell	2003
Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells T Standal, C Seidel, Ø Hjertner, T Plesner, RD Sanderson, A Waage, M Borset, A Sundan	Blood	2002
Analysis of the Infectious Entry Pathway of Human Papillomavirus Type 33 Pseudovirions HC Selinka, T Giroglou, M Sapp	Virology	2002
Not All Perlecans Are Created Equal: INTERACTIONS WITH FIBROBLAST GROWTH FACTOR (FGF) 2 AND FGF RECEPTORS S Knox, C Merry, S Stringer, J Melrose, J Whitelock	The Journal of biological chemistry	2002
Differential Role of Heparan Sulfate Proteoglycans on Aggregated LDL Uptake in Human Vascular Smooth Muscle Cells and Mouse Embryonic Fibroblasts V Llorente-Cortés, M Otero-Viñas, L Badimon	Arteriosclerosis, thrombosis, and vascular biology	2002
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface BS Sachais, A Kuo, T Nassar, J Morgan, K Kariko, KJ Williams, M Feldman, M Aviram, N Shah, L Jarett, M Poncz, DB Cines, AA Higazi	Blood	2002
Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice A Auger, TQ Truong, D Rhainds, J Lapointe, F Letarte, L Brissette	European Journal of Biochemistry	2001
Intracellular metabolism of triglyceride-rich lipoproteins J Heeren, U Beisiegel	Current Opinion in Lipidology	2001
The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface J Cladera, I Martin, P O'Shea	The EMBO Journal	2001
Developmental roles of the glypicans BD Cat, G David	Seminars in Cell & Developmental Biology	2001
Lipoprotein Lipase Mediates the Uptake of Glycated LDL in Fibroblasts, Endothelial Cells, and Macrophages R Zimmermann, U Panzenbock, A Wintersperger, S Levak-Frank, W Graier, O Glatter, G Fritz, GM Kostner, R Zechner	Diabetes	2001
The Triple Threat to Nascent Apolipoprotein B: EVIDENCE FOR MULTIPLE, DISTINCT DEGRADATIVE PATHWAYS EA Fisher, M Pan, X Chen, X Wu, H Wang, H Jamil, JD Sparks, KJ Williams	The Journal of biological chemistry	2001
Bile salt-dependent lipase: its pathophysiological implications D Lombardo	Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids	2001
The Apolipoprotein E-dependent Low Density Lipoprotein Cholesteryl Ester Selective Uptake Pathway in Murine Adrenocortical Cells Involves Chondroitin Sulfate Proteoglycans and an α 2 -Macroglobulin Receptor S Swarnakar, J Beers, DK Strickland, S Azhar, DL Williams	The Journal of biological chemistry	2001
Structural Characterization of Heparan Sulfate and Chondroitin Sulfate of Syndecan-1 Purified from Normal Murine Mammary Gland Epithelial Cells: COMMON PHOSPHORYLATION OF XYLOSE AND DIFFERENTIAL SULFATION OF GALACTOSE IN THE PROTEIN LINKAGE REGION TETRASACCHARIDE SEQUENCE M Ueno, S Yamada, M Zako, M Bernfield, K Sugahara	The Journal of biological chemistry	2001
Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease C Seidel, Ø Hjertner, N Abildgaard, L Heickendorff, M Hjorth, J Westin, JL Nielsen, H Hjorth-Hansen, A Waage, A Sundan, M Børset	Blood	2001
Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice HL Dichek, SM Johnson, H Akeefe, GT Lo, E Sage, CE Yap, RW Mahley	Journal of lipid research	2001
Syndecan‐4 up‐regulation in proliferative renal disease is related to microfilament organization S Yung, A Woods, TM Chan, M Davies, JD Williams, JR Couchman	The FASEB Journal	2001
Transmembrane and cytoplasmic domains of syndecan mediate a multi-step endocytic pathway involving detergent-insoluble membrane rafts IV Fuki, ME Meyer, KJ Williams	Biochemical Journal	2000
Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions S Tumova, A Woods, JR Couchman	The International Journal of Biochemistry & Cell Biology	2000
Syndecans and the Lymphoid System L Kopper	Leukemia & Lymphoma	2000
Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport KJ Williams, R Scalia, KD Mazany, WV Rodrigueza, AM Lefer	Arteriosclerosis, thrombosis, and vascular biology	2000
Placental expression of syndecan 1 is diminished in preeclampsia VI Jokimaa, HP Kujari, EM Ekholm, PL Inki, L Anttila	American Journal of Obstetrics and Gynecology	2000
Participation of Syndecan 2 in the Induction of Stress Fiber Formation in Cooperation with Integrin α5β1: Structural Characteristics of Heparan Sulfate Chains with Avidity to COOH-Terminal Heparin-Binding Domain of Fibronectin Y Kusano, K Oguri, Y Nagayasu, S Munesue, M Ishihara, I Saiki, H Yonekura, H Yamamoto, M Okayama	Experimental Cell Research	2000
Proteoglycans: Structure, Biology And Molecular Interactions H Song, J Filmus	Proteoglycans: Structure, Biology And Molecular Interactions	2000
Perlecan Heparan Sulfate Proteoglycan: A NOVEL RECEPTOR THAT MEDIATES A DISTINCT PATHWAY FOR LIGAND CATABOLISM IV Fuki, RV Iozzo, KJ Williams	The Journal of biological chemistry	2000
Endogenously produced glycosaminoglycans affecting the release of lipoprotein lipase from macrophages and the interaction with lipoproteins R Zimmermann, P Sartipy, R Winkler, R Zechner, E Hurt-Camejo, GM Kostner	Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids	2000
Proliferative Effect of Lipoprotein Lipase on Human Vascular Smooth Muscle Cells JC Mamputu, L Levesque, G Renier	Arteriosclerosis, thrombosis, and vascular biology	2000
Lipoprotein lipase-mediated interactions of small proteoglycans and low-density lipoproteins E Schönherr, B Zhao, H Hausser, M Müller, C Langer, WD Wagner, IJ Goldberg, H Kresse	European Journal of Cell Biology	2000
Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor–related protein JG Neels, BM van den Berg, K Mertens, H ter Maat, H Pannekoek, AJ van Zonneveld, PJ Lenting	Blood	2000
Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosis AM Olofsson, M Vestberg, H Herwald, J Rygaard, G David, KE Arfors, V Linde, H Flodgaard, J Dedio, W Müller-Esterl, E Lundgren-Akerlund	Journal of Clinical Investigation	1999
Characterization of low-density lipoprotein uptake by murine macrophages exposed to Chlamydia pneumoniae MV Kalayoglu, GS Miranpuri, DT Golenbock, GI Byrne	Microbes and Infection	1999
Functions of cell surface heparan sulfate proteoglycans M Bernfield, M Götte, PW Park, O Reizes, ML Fitzgerald, J Lincecum, M Zako	Annual Review of Biochemistry	1999
Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site V V Shuvaev, J Fujii, Y Kawasaki, H Itoh, R Hamaoka, A Barbier, O Ziegler, G Siest, N Taniguchi	Biochimica et Biophysica Acta	1999
Recycling of Apolipoprotein E in Mouse Liver S Fazio, MR Linton, AH Hasty, LL Swift	The Journal of biological chemistry	1999
Scavenger Receptor Class B, Type I, Mediates Selective Uptake of Low Density Lipoprotein Cholesteryl Ester S Swarnakar, RE Temel, MA Connelly, S Azhar, DL Williams	The Journal of biological chemistry	1999
Sortilin/Neurotensin Receptor-3 Binds and Mediates Degradation of Lipoprotein Lipase MS Nielsen, C Jacobsen, G Olivecrona, J Gliemann, CM Petersen	The Journal of biological chemistry	1999
The syndecans, tuners of transmembrane signaling P Zimmermann, G DAVID	The FASEB Journal	1999
Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E RW Mahley, ZS Ji	Journal of lipid research	1999
Regulated turnover of a cell surface-associated pool of newly synthesized apolipoprotein E in HepG2 cells M Schmitt, T Grand-Perret	Journal of lipid research	1999
Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes RW Mahley, Y Huang, SC Rall	Journal of lipid research	1999
Syndecan-4 and integrins: combinatorial signaling in cell adhesion JR Couchman, A Woods	Journal of cell science	1999
Receptor-mediated mechanisms of lipoprotein remnant catabolism DA Chappell, JD Medh	Progress in Lipid Research	1998
Structural and metabolic consequences of liposome–lipoprotein interactions WV Rodrigueza, MC Phillips, KJ Williams	Advanced Drug Delivery Reviews	1998
Association of apo B lipoproteins with arterial proteoglycans: Pathological significance and molecular basis G Camejo, E Hurt-Camejo, O Wiklund, G Bondjers	Atherosclerosis	1998
Proteoglycans in macrophages: characterization and possible role in the cellular uptake of lipoproteins B Halvorsen, UK Aas, MA Kulseth, CA Drevon, EN Christiansen, SO Kolset	Biochemical Journal	1998
Molecular interactions of the syndecan core proteins AC Rapraeger, VL Ott	Current Opinion in Cell Biology	1998
Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4 ZS Ji, RE Pitas, RW Mahley	The Journal of biological chemistry	1998
Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice N Wang, T Arai, Y Ji, F Rinninger, AR Tall	The Journal of biological chemistry	1998
Human chondroitin 6-sulfotransferase: cloning, gene structure, and chromosomal localization K D Mazany, T Peng, C E Watson, I Tabas, K J Williams	Biochimica et Biophysica Acta	1998
Selective Uptake of Low Density Lipoprotein-Cholesteryl Ester Is Enhanced by Inducible Apolipoprotein E Expression in Cultured Mouse Adrenocortical Cells S Swarnakar, ME Reyland, J Deng, S Azhar, DL Williams	The Journal of biological chemistry	1998
Heparan Sulfate Proteoglycans as Adhesive and Anti-invasive Molecules: SYNDECANS AND GLYPICAN HAVE DISTINCT FUNCTIONS W Liu, ED Litwack, MJ Stanley, JK Langford, AD Lander, RD Sanderson	The Journal of biological chemistry	1998
Binding and intracellular trafficking of lipoprotein lipase and triacylglycerol-rich lipoproteins by liver cells RP Casaroli-Marano, R García, E Vilella, G Olivecrona, M Reina, S Vilaró	Journal of lipid research	1998
Lipoprotein lipase mediates an increase in the selective uptake of high density lipoprotein-associated cholesteryl esters by hepatic cells in culture F Rinninger, T Kaiser, WA Mann, N Meyer, H Greten, U Beisiegel	Journal of lipid research	1998
Review M Epstein	Renal Failure	1996
International Review of Cytology RA Miller	International Review of Cytology	1991

Advertisement